Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Sir Gordon Duff has been awarded an Honorary Senior Fellowship at NDORMS.

Sir Gordon Duff

The former Principal of St Hilda's College, Oxford, and University Pro-Vice Chancellor, joined NDORMS in July 2021 with a focus on translational medicine and the development of modern therapeutics.

Sir Gordon was past-Chair of BBSRC, SAGE and MHRA and is now dedicated to improving human health through planetary health. He played a pivotal role in the appointment of Oxford's first Climax Chair of Clinical Therapeutics, Professor Duncan Richards, and in the University's plans to establish a new Oxford Experimental Medicine Clinical Research Facility (Oxford EMCRF) within NDORMS.

Commenting on his Fellowship Sir Gordon said: "I feel privileged with this honorary appointment in NDORMS, one of the leading Departments in any Medical School worldwide, and look forward to contributing what I can to the continued success of NDORMS in pioneering health advances."

Head of Department Professor Andrew Carr said; "It is a great pleasure to welcome Sir Gordon as a Senior Research Fellow in NDORMS. He has a long association with the department and his knowledge and insights will provide a considerable boost to many of our activities."

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.